CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Market Signals

Mar 13 2026 08:01 AM IST
share
Share Via
CARE Ratings Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a nuanced market sentiment. Despite a modest daily gain of 1.74%, the stock’s technical indicators present a complex picture, with bullish signals on weekly charts contrasting with mildly bearish monthly trends. This article analyses the recent technical developments, price momentum, and comparative performance against the Sensex to provide a comprehensive outlook for investors.
CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Market Signals

Price Momentum and Recent Trading Range

CARE Ratings Ltd closed at ₹1,634.60 on 13 Mar 2026, up from the previous close of ₹1,606.65, marking a daily increase of 1.74%. The stock traded within a range of ₹1,567.15 to ₹1,645.75 during the session, indicating moderate intraday volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹1,057.65 and a high of ₹1,964.80, underscoring a significant price appreciation potential within this period.

The shift from a mildly bearish to a sideways technical trend suggests that the stock is consolidating after a period of downward pressure. This consolidation phase often precedes a decisive directional move, making it critical for investors to monitor key technical indicators closely.

Technical Indicator Analysis: Divergent Signals

The Moving Average Convergence Divergence (MACD) indicator presents a mixed outlook. On a weekly basis, the MACD is bullish, signalling positive momentum and potential upward price movement. Conversely, the monthly MACD remains mildly bearish, indicating that longer-term momentum has yet to fully recover. This divergence suggests that while short-term traders may find opportunities, longer-term investors should exercise caution.

The Relative Strength Index (RSI) offers no clear signal on either weekly or monthly charts, hovering in a neutral zone. This lack of momentum extremes implies that the stock is neither overbought nor oversold, consistent with the sideways trend observed.

Bollinger Bands reinforce the bullish sentiment on both weekly and monthly timeframes, with price action gravitating towards the upper band. This typically indicates increased buying interest and potential for further gains, although the absence of RSI confirmation tempers enthusiasm.

Daily moving averages remain mildly bearish, reflecting recent price softness in the short term. This suggests that while weekly momentum is positive, daily price action is still under some pressure, possibly due to profit-taking or sector-specific factors.

Additional Technical Measures: KST, Dow Theory, and OBV

The Know Sure Thing (KST) indicator aligns with the MACD, showing bullish momentum on weekly charts but mildly bearish readings monthly. This further emphasises the divergence between short- and long-term trends.

Dow Theory analysis reveals no clear trend on a weekly basis but indicates a mildly bullish stance monthly. This suggests that the broader market perception of CARE Ratings Ltd is cautiously optimistic over the medium term.

On-Balance Volume (OBV) data shows no trend weekly and a mildly bearish tone monthly, signalling that volume flow has not decisively supported price gains recently. This volume-price divergence warrants attention as it may indicate underlying weakness despite price advances.

Comparative Performance Versus Sensex

CARE Ratings Ltd has outperformed the Sensex significantly across multiple time horizons. Over the past week, the stock gained 0.36% while the Sensex declined 4.98%. The one-month return for CARE Ratings was 1.06%, compared to a 9.13% drop in the Sensex. Year-to-date, CARE Ratings has appreciated 2.11%, whereas the Sensex has fallen 10.78%.

Longer-term returns are even more impressive. Over one year, CARE Ratings surged 42.39%, dwarfing the Sensex’s 2.71% gain. Over three and five years, the stock’s returns stand at 142.25% and 256.82%, respectively, vastly outperforming the Sensex’s 28.58% and 49.70% gains. However, over a ten-year horizon, the Sensex leads with a 207.61% return compared to CARE Ratings’ 81.72%, reflecting the stock’s more recent acceleration.

Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!

  • - Long-term growth stock
  • - Multi-quarter performance
  • - Sustainable gains ahead

Invest for the Long Haul →

Mojo Score and Rating Upgrade

CARE Ratings Ltd currently holds a Mojo Score of 54.0, placing it in the 'Hold' category. This represents an upgrade from its previous 'Sell' rating as of 12 Mar 2026, reflecting improved technical and fundamental assessments. The company is classified as a small-cap within the capital markets sector, which often entails higher volatility but also greater growth potential.

The upgrade to a Hold rating aligns with the observed technical momentum shift and the stock’s relative outperformance versus the broader market. However, the modest score indicates that investors should remain cautious and monitor developments closely, especially given the mixed signals from monthly indicators.

Sector Context and Market Capitalisation

Operating within the capital markets industry, CARE Ratings Ltd is positioned in a sector sensitive to economic cycles and regulatory changes. The small-cap market capitalisation grade suggests that while the company may offer attractive growth prospects, it is also subject to liquidity constraints and higher risk compared to larger peers.

Investors should weigh these factors alongside the technical signals to determine appropriate portfolio positioning. The sideways trend and mixed indicator readings imply a period of consolidation, where risk management and selective entry points will be crucial.

Is CARE Ratings Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Outlook and Investor Considerations

CARE Ratings Ltd’s technical landscape is characterised by a cautious optimism. The bullish weekly MACD and Bollinger Bands suggest that short-term momentum is improving, while the sideways trend indicates a pause in the recent bearish pressure. However, the mildly bearish monthly MACD and OBV, alongside neutral RSI readings, counsel prudence for longer-term investors.

Given the stock’s strong relative performance against the Sensex over one to five years, CARE Ratings has demonstrated resilience and growth potential. Yet, the divergence in technical signals highlights the importance of monitoring volume trends and moving averages closely to confirm any sustained breakout or breakdown.

Investors should consider the stock’s small-cap status and sector-specific risks, balancing these against the potential for further gains as indicated by the weekly bullish momentum. A disciplined approach, incorporating stop-loss levels and position sizing, is advisable in navigating the current technical environment.

In summary, CARE Ratings Ltd is transitioning from a mildly bearish phase into a consolidation zone with mixed technical signals. The upgrade to a Hold rating and improved Mojo Score reflect this evolving outlook, suggesting that while the stock is not yet a clear buy, it warrants close attention for potential entry points as momentum indicators align more favourably.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News